Shanxi Cardiovascular Hospital

The trials here

What the 25 trials at this site are about, from their registry records.

Conditions

• Stroke9 trials
• Atrial fibrillation6 trials
• Heart failure6 trials
• Coronary artery disease5 trials
• Aortic stenosis1 trial
• Brain aneurysm1 trial
• Migraine1 trial
• Obesity1 trial

Phase

• Phase 313 trials

Status

• Completed8 trials
• Recruiting7 trials
• Active, not recruiting5 trials
• Not yet recruiting5 trials

Lead sponsor

• Beijing Tiantan Hospital3 trials
• Janssen Research & Development, LLC3 trials
• Boehringer Ingelheim2 trials
• Capital Medical University2 trials
• Second Affiliated Hospital, Zhejiang University, School of Medicine2 trials
• and 13 more

Running trials

• Not yet recruiting

  Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients

  NCT07725484· Phase 3· Shanghai Zhongshan Hospital· Source

  Contact: Xiurui Ma

• Not yet recruiting

  Ongericimab Injection Reducing Recurrence of Ischemic Stroke

  NCT07242599· Phase 3· Beijing Tiantan Hospital· Source

  Contact: Chen Chen

• Recruiting

  Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)

  NCT07389460· Phase 3· First Affiliated Hospital Xi'an Jiaotong University· Source

  Contact: Weirong Li, MD

• Recruiting

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2

  NCT07139314· Capital Medical University· Source

  Contact: Qiong Hu

• Active, not recruiting

  Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation

  NCT07139301· Capital Medical University· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Amgen· Source

• Recruiting

  A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  NCT06935370· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia

  NCT06686485· Boston Scientific Corporation· Source

• Not yet recruiting

  Deep Sedation in Catheter Ablation of Atrial Fibrillation

  NCT06836999· The First Affiliated Hospital of Dalian Medical University· Source

  Contact: Haixiong Wang

• Recruiting

  Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  NCT06736574· Phase 3· Cytokinetics· Source

  Contact: Cytokinetics MD

• Active, not recruiting

  FFR Versus IVUS With Angiography-Derived FFR for Clinical Outcomes in Patients With Coronary Artery Disease

  NCT06218485· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Not yet recruiting

  Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

  NCT04995159· Lepu Medical Technology (Beijing) Co., Ltd.· Source

  Contact: Jian An

• Recruiting

  Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

  NCT04948749· Beijing Tiantan Hospital· Source

  Contact: Dong Kuai

• Recruiting

  HANGZHOU Solution in Bicuspid AS Undergoing TAVR

  NCT04722796· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source

  Contact: Jian An

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke5 recruiting
• Heart failure4 recruiting
• Atrial fibrillation2 recruiting
• Coronary artery disease2 recruiting
• Aortic stenosis1 recruiting
• Obesity1 recruiting

Closed trials

• Completed

  China 3T MRI Study

  NCT06038123· Medtronic Cardiac Rhythm and Heart Failure· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Evaluate Safety and Efficacy of Alveo HP Balloon Dilatation Catheter for Balloon Dilatation of Coronary Artery Stenosis

  NCT05998252· BrosMed Medical Co., Ltd· Source

• Completed

  Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)

  NCT05439356· Phase 3· Beijing Tiantan Hospital· Source

• Completed

  Efficacy and Safety of PFO Closure vs Medical Therapy in Alleviating Migraine

  NCT04946734· Phase 3· Guangdong Provincial People's Hospital· Source

• Completed

  Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China

  NCT04747496· Daiichi Sankyo· Source

• Completed

  Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure

  NCT04468529· Phase 3· Zensun Sci. & Tech. Co., Ltd.· Source

• Recruiting

  Neurovascular Product Surveillance Registry

  NCT02988128· Medtronic Neurovascular Clinical Affairs· Source

  Contact: Wouter Fabry